Anne-Vibeke Lænkholm

Anne-Vibeke Lænkholm

Clinical Associate Professor

Member of:

  • Pathology

ORCID: 0000-0003-2166-8686

Publication year:
All
1 - 8 out of 8Page size: 10
  1. 2015
  2. Published

    Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

    Thomsen, K. G., Lyng, M. B., Elias, D., Vever, H., Knoop, A. S., Lykkesfeldt, A. E., Lænkholm, Anne-Vibeke & Ditzel, H. J., Dec 2015, In: Breast Cancer Research and Treatment. 154, 3, p. 483-94 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer

    Lund, R. R., Leth-Larsen, R., Caterino, T. D., Terp, M. G., Nissen, J., Lænkholm, Anne-Vibeke, Jensen, O. N. & Ditzel, H. J., Nov 2015, In: Molecular and Cellular Proteomics. 14, 11, p. 2988-99 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells

    Thrane, Susan, Pedersen, A. M., Thomsen, M. B. H., Kirkegaard, T., Rasmussen, B. B., Duun-Henriksen, A. K., Lænkholm, Anne-Vibeke, Bak, M., Lykkesfeldt, A. E. & Yde, C. W., 6 Aug 2015, In: Oncogene. 34, 32, p. 4199-210 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

    Elias, D., Vever, H., Lænkholm, Anne-Vibeke, Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E. & Ditzel, H. J., 9 Apr 2015, In: Oncogene. 34, 15, p. 1919-27 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

    Larsen, S. L., Yde, C. W., Lænkholm, Anne-Vibeke, Rasmussen, B. B., Duun-Henriksen, A. K., Bak, M., Lykkesfeldt, A. E. & Kirkegaard, T., 8 Apr 2015, In: B M C Cancer. 15, 15 p., 239.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    An international study to increase concordance in Ki67 scoring

    Polley, M-Y. C., Leung, S. C. Y., Gao, D., Mastropasqua, M. G., Zabaglo, L. A., Bartlett, J. M. S., McShane, L. M., Enos, R. A., Badve, S. S., Bane, A. L., Borgquist, S., Fineberg, S., Lin, M-G., Gown, A. M., Grabau, D., Gutierrez, C., Hugh, J. C., Moriya, T., Ohi, Y., Osborne, C. K. & 11 others, Penault-Llorca, F. M., Piper, T., Porter, P. L., Sakatani, T., Salgado, R., Starczynski, J., Lænkholm, Anne-Vibeke, Viale, G., Dowsett, M., Hayes, D. F. & Nielsen, T. O., 2015, In: Modern Pathology. 28, 6, p. 778-86 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis

    Krøigård, A. B., Larsen, M. J., Lænkholm, Anne-Vibeke, Knoop, A. S., Jensen, J. D., Bak, M., Mollenhauer, J., Kruse, T. A. & Thomassen, M., 2015, In: OncoTarget. 6, 8, p. 5634-49 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment

    Larsen, S. L., Lænkholm, Anne-Vibeke, Duun-Henriksen, A. K., Bak, M., Lykkesfeldt, A. E. & Kirkegaard, T., 2015, In: PloS one. 10, 2, e0118346.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 102813499